Molecular characterization of acquired resistance to the BRAF inhibitor dabrafenib in a patient with BRAF-mutant non-small-cell lung cancer

Charles M. Rudin; Kelvin Hong; Michael Streit

doi:10.1097/JTO.0b013e31828bb1b3

Molecular characterization of acquired resistance to the BRAF inhibitor dabrafenib in a patient with BRAF-mutant non-small-cell lung cancer

Charles M. Rudin
, Kelvin Hong
, Michael Streit

School of Medicine

Research output: Contribution to journal › Article › peer-review

63 Scopus citations

Original language	English (US)
Pages (from-to)	e41-e42
Journal	Journal of Thoracic Oncology
Volume	8
Issue number	5
DOIs	https://doi.org/10.1097/JTO.0b013e31828bb1b3
State	Published - May 2013

ASJC Scopus subject areas

Oncology
Pulmonary and Respiratory Medicine

Access to Document

10.1097/JTO.0b013e31828bb1b3

Cite this

@article{f32d16ac06bf4813a17d5b85115c7503,

title = "Molecular characterization of acquired resistance to the BRAF inhibitor dabrafenib in a patient with BRAF-mutant non-small-cell lung cancer",

author = "Rudin, \{Charles M.\} and Kelvin Hong and Michael Streit",

year = "2013",

month = may,

doi = "10.1097/JTO.0b013e31828bb1b3",

language = "English (US)",

volume = "8",

pages = "e41--e42",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Molecular characterization of acquired resistance to the BRAF inhibitor dabrafenib in a patient with BRAF-mutant non-small-cell lung cancer

AU - Rudin, Charles M.

AU - Hong, Kelvin

AU - Streit, Michael

PY - 2013/5

Y1 - 2013/5

UR - https://www.scopus.com/pages/publications/84876419277

UR - https://www.scopus.com/pages/publications/84876419277#tab=citedBy

U2 - 10.1097/JTO.0b013e31828bb1b3

DO - 10.1097/JTO.0b013e31828bb1b3

M3 - Article

C2 - 23524406

AN - SCOPUS:84876419277

SN - 1556-0864

VL - 8

SP - e41-e42

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 5

ER -

Molecular characterization of acquired resistance to the BRAF inhibitor dabrafenib in a patient with BRAF-mutant non-small-cell lung cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this